Company Overview and News

1
IL&FS plans to raise authorized share capital

21h livemint
Mumbai: Infrastructure Leasing and Financial Services Ltd (IL&FS) is planning to boost its authorized share capital by ₹ 4,000-5,000 crore to enable the cash-strapped group to raise money from its shareholders. The move is aimed at meeting the group’s immediate repayment obligations and avoiding further debt rating downgrades, according to two people with direct knowledge of IL&FS Group’s plans.
HDFC IX 500010 HDFC SBAZ

 
IL&FS plans fire sale of financial services unit

2018-09-21 livemint
Mumbai/New Delhi: Infrastructure Leasing and Financial Services Ltd (IL&FS) is planning to sell a majority stake in its financial services unit and additional assets worth ₹ 4,500 crore to pay down debts as the company rushes to meet its obligations and avoid bankruptcy. IL&FS has also asked the government to clear dues worth as much as ₹ 16,000 crore for work completed by the company, three executives familiar with the development said, requesting anonymity.
HDFC 500010 HDFC SBAZ

1
Shareholders put a rider ahead of IL&FS bailout talks

2018-09-19 livemint
Mumabi: Key shareholders of cash-starved Infrastructure Leasing and Financial Services Ltd (IL&FS) have asked the management to table a comprehensive turnaround and deleveraging plan, before talks of a potential bailout can be initiated, said two people directly aware of the development. “The decision of shareholders led by Life Insurance Corporation of India (LIC) was conveyed to the IL&FS top management during the company’s board meeting held on 15 September,” said the first person cited above, requesting anonymity.
HDFC IX 500010 HDFC SBAZ

1
Crisis-ridden ILFS under regulatory scanner for alleged corporate governance, disclosure lapses

2018-09-18 moneycontrol
Crisis-ridden infrastructure conglomerate IL&FS group, once hailed as a pioneer of public-private partnership, has come under the scanner of multiple regulators, including SEBI, for alleged defaults related to financial disclosures and corporate governance, officials said.
HDFC IX 500010 HDFC

 
IL&FS: It’s time for a surgery, not band-aid

2018-09-17 livemint
The question prospective rescuers of Infrastructure Leasing and Financial Services Ltd (IL&FS) should be asking is whether they should treat the symptoms or the disease. Life Insurance Corporation of India (LIC) is apparently readying a bailout and is likely to be in a position to effect management changes, subsequently.
500116 IDBI HDFC 500010 HDFC SBAZ

 
Exclusive | HDFC refuses to give loans to cash-starved ILFS

2018-09-14 moneycontrol
In need of cash but IL&FS will not receive any funds from HDFC - Housing Development Finance Corporation - one of its large shareholders.
HDFC 500010 HDFC SBAZ

3
IL&FS board fails to decide on raising funds from investors

2018-09-07 livemint - 2
Mumbai: Infrastructure Leasing and Financial Services Ltd (IL&FS), the unlisted parent to a cluster of companies in various infrastructure verticals, failed to raise immediate funds from shareholders at a snap board meeting on Friday.
HDFC IX 500010 HDFC SBAZ

 
Check out insider trades for August 31; IDFC Bank, Liberty Shoes, HDFC in focus

2018-09-03 moneycontrol
Camlin Fine Sciences.: Ashish Subhash Dandekar (promoter) bought 1,38,10,550 shares through market purchase on August 30 and August 31, 2018
LIBERTSHOE PANAMAPET 533260 533298 HDFC 532834 539437 IDFCBANK CAREERP SURANASOL 526596 524820 CAMLINFIN 500010 HDFC

3
Check out insider trades for August 24; Bajaj Finance, Yes Bank, HDFC, Axis Bank in focus

2018-08-29 moneycontrol
Motor & General Finance: GEE GEE Holdings Pvt.Ltd (promoter) bought 3,33,857 shares through market purchase on August 24, 2018
GFN YESBANK GFNCP AXB ONWARDTEC 517536 ORIENTBELL 532648 YYBKY HDFC GFNSL 532215 AXBKY BRK.A 530365 AXBA BAJFINANCE AXISBANK BJJQY GFDV 500010 HDFC 500034

 
HDFC AMC hits all-time high

2018-08-24 thehindubusinessline
Shares of HDFC Asset Management Company defied the broader market sentiment and hit record highs. The stock jumped as much as five per cent on strong June quarter results.
HDFC 500010 HDFC

 
HDFC AMC profit rises 25% to ₹205.26 crore in June quarter

2018-08-21 livemint
New Delhi: HDFC Asset Management Company, the country’s second-largest mutual fund house, on Tuesday reported a 25% surge in net profit at₹205.26 crore for three months ended 30 June this year.
HDFC 500010 HDFC

 
HDFC plans special situations fund to invest in stressed realty projects

2018-08-19 livemint
Bengaluru: Housing Development Finance Corp. Ltd (HDFC), India’s largest mortgage lender, is setting up a new venture to raise capital for a special situations fund that will invest in stressed projects in real estate. HDFC, which will be a sponsor to the fund, is in talks with investors to raise capital through the alternative investment fund (AIF) route. Kaizad Hazari has been appointed as chief executive officer-designate for the venture.
HDFC 500010 HDFC

 
Check out insider trades for August 14; Kotak Mahindra Bank, HDFC, Yes Bank in focus

2018-08-18 moneycontrol
Kotak Mahindra Bank Ltd: Farida Khambata bought 40,000 shares through market purchase on August 14, 2018
GFN YESBANK GFNCP BERGEPAINT 509480 KMBKY 500228 532648 YYBKY HDFC GFNSL JSWSTEEL KOTAKBANK GFDV 500247 500010 HDFC

1
HDFC shares react over exit of Sukthankar

2018-08-14 freepressjournal.in
Mumbai : HDFC Bank’s announced late Friday evening that Deputy Managing Director Paresh Sukthankar was exiting the bank caught the market by surprise and led to questions about the bank’s succession plans, even as some media reports suggested he might be heading for the top post at Axis Bank.
AXBKY AXBA AXB HDB AXISBANK 500180 HDFCBANK HDFC 500010 HDFC 532215

 
Check out insider trades for August 9; Axis Bank, ICICI Bank, Jubilant FoodWorks in focus

2018-08-13 moneycontrol
K.M.Sugar Mills Ltd.: Umadevi Jhunjhunwala bought 1,77,831 shares through market purchase from August 7 to August 9, 2018
SRIPIPES AXB 500228 IBN HDFC 533155 JUBLFOOD JSWSTEEL 532215 AXBKY AXBA 532387 ICICIBANK AXISBANK 532174 513605 JBLWY PNC 500010 HDFC

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...